Anti-proliferative and antibacterial in vitro evaluation of the polyurethane nanostructures incorporating pentacyclic triterpenes. (1st November 2016)
- Record Type:
- Journal Article
- Title:
- Anti-proliferative and antibacterial in vitro evaluation of the polyurethane nanostructures incorporating pentacyclic triterpenes. (1st November 2016)
- Main Title:
- Anti-proliferative and antibacterial in vitro evaluation of the polyurethane nanostructures incorporating pentacyclic triterpenes
- Authors:
- Oprean, Camelia
Zambori, Csilla
Borcan, Florin
Soica, Codruta
Zupko, Istvan
Minorics, Renata
Bojin, Florina
Ambrus, Rita
Muntean, Delia
Danciu, Corina
Pinzaru, Iulia Andreea
Dehelean, Cristina
Paunescu, Virgil
Tanasie, Gabriela - Abstract:
- Abstract: Context: Oleanolic and ursolic acids are antitumor and antibacterial agents which are extensively studied. Their major disadvantage is the poor water solubility which limits their applications. Objectives: Oleanolic and ursolic acid were encapsulated into polyurethane nanostructures that act as drug carriers. In order to evaluate the effectiveness of the particles, anti-microbial and anti-proliferative activity compared to un-encapsulated active compounds was tested. Materials and methods: Using an interfacial polycondensation technique, combined with spontaneous emulsification, structures with nanoscale dimensions were obtained. Scanning electron microscopy, differential scanning calorimetry and X-ray assays confirmed the encapsulation process. Concentrations of 10 and 30 μM particles and un-encapsulated compounds were tested by MTT viability assay for several breast cancer lines, with an exposure time of 72 h. For the antibacterial studies, the dilution method with MIC determination was used. Results: Ursolic acid had an excellent inhibitory effect with IC50 value of 2.47, 1.20, 1.26 and 1.34 μM on MCF7, T47D, MDA-MB-231 and MDA-MB-361, respectively. Oleanolic acid did not show anti-proliferative activity. The pure compounds showed their antibacterial activity only against Bacillus species and Candida albicans, but MIC values were too high to be considered efficient antimicrobial agents (2280 and 4570 μg mL − 1, respectively). Polyurethane nanoparticles whichAbstract: Context: Oleanolic and ursolic acids are antitumor and antibacterial agents which are extensively studied. Their major disadvantage is the poor water solubility which limits their applications. Objectives: Oleanolic and ursolic acid were encapsulated into polyurethane nanostructures that act as drug carriers. In order to evaluate the effectiveness of the particles, anti-microbial and anti-proliferative activity compared to un-encapsulated active compounds was tested. Materials and methods: Using an interfacial polycondensation technique, combined with spontaneous emulsification, structures with nanoscale dimensions were obtained. Scanning electron microscopy, differential scanning calorimetry and X-ray assays confirmed the encapsulation process. Concentrations of 10 and 30 μM particles and un-encapsulated compounds were tested by MTT viability assay for several breast cancer lines, with an exposure time of 72 h. For the antibacterial studies, the dilution method with MIC determination was used. Results: Ursolic acid had an excellent inhibitory effect with IC50 value of 2.47, 1.20, 1.26 and 1.34 μM on MCF7, T47D, MDA-MB-231 and MDA-MB-361, respectively. Oleanolic acid did not show anti-proliferative activity. The pure compounds showed their antibacterial activity only against Bacillus species and Candida albicans, but MIC values were too high to be considered efficient antimicrobial agents (2280 and 4570 μg mL − 1, respectively). Polyurethane nanoparticles which incorporated the agents did not show any biological activity. Discussion and conclusion: Although the active compounds did not fully exert their anti-proliferative activity following encapsulation inside polymeric nanoparticles, in vivo evaluation is needed in order to obtain an exhaustive conclusion, as the active compounds could be released as a result of metabolic activity. … (more)
- Is Part Of:
- Pharmaceutical biology. Volume 54:Number 11(2016:Nov.)
- Journal:
- Pharmaceutical biology
- Issue:
- Volume 54:Number 11(2016:Nov.)
- Issue Display:
- Volume 54, Issue 11 (2016)
- Year:
- 2016
- Volume:
- 54
- Issue:
- 11
- Issue Sort Value:
- 2016-0054-0011-0000
- Page Start:
- 2714
- Page End:
- 2722
- Publication Date:
- 2016-11-01
- Subjects:
- Antitumor -- breast cancer -- minimal inhibitory concentration -- oleanolic acid -- ursolic acid
Pharmacognosy -- Periodicals
Materia medica, Vegetable -- Periodicals
615.321 - Journal URLs:
- http://www.tandfonline.com/toc/iphb20/current ↗
http://informahealthcare.com/journal/phb ↗
http://informahealthcare.com ↗ - DOI:
- 10.1080/13880209.2016.1180538 ↗
- Languages:
- English
- ISSNs:
- 1388-0209
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 6442.767000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 2610.xml